EMA recommends indication expansion for Lundbeck drug
The European Medicines Agency EMA has recommended authorization of an indication extension concerning the Lundbeck drug Abilify Maintena, according to the pharmaceutical firm.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.